{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:07:22Z","timestamp":1790539642383,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1053\/j.semdp.2016.12.007","type":"journal-article","created":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T17:01:22Z","timestamp":1482253282000},"page":"112-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Hepatocellular adenoma: Classification, variants and clinical relevance"],"prefix":"10.1053","volume":"34","author":[{"given":"Paulette","family":"Bioulac-Sage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Sempoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Balabaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semdp.2016.12.007_bib1","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1053\/j.gastro.2013.02.032","article-title":"Hepatocellular benign tumors-from molecular classification to personalized clinical care","volume":"144","author":"Nault","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1053\/j.semdp.2016.12.007_bib2","unstructured":"Bioulac-Sage P, Balabaud C, Wanless IR. Lyon: IARC. Focal nodular hyperplasia and hepatocellular adenoma. in: WHO Classification of Tumours of the Digestive System; in Bosman FT, Carneiro F, Hruban RH. Theise ND (Eds.), ed4; 2010:198\u2013204."},{"key":"10.1053\/j.semdp.2016.12.007_bib3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ng1001","article-title":"Bi-allelic inactivation of TCF1 in hepatic adenomas","volume":"32","author":"Bluteau","year":"2002","journal-title":"Nat Genet"},{"key":"10.1053\/j.semdp.2016.12.007_bib4","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.gastro.2003.07.012","article-title":"Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation","volume":"125","author":"Bacq","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1053\/j.semdp.2016.12.007_bib5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cytogfr.2015.07.010","article-title":"Mutations leading to constitutive active gp130\/JAK1\/STAT3 pathway","volume":"26","author":"Pilati","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1053\/j.semdp.2016.12.007_bib6","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nature07475","article-title":"Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours","volume":"457","author":"Rebouissou","year":"2009","journal-title":"Nature"},{"key":"10.1053\/j.semdp.2016.12.007_bib7","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ccr.2014.03.005","article-title":"Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation","volume":"25","author":"Pilati","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1053\/j.semdp.2016.12.007_bib8","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1084\/jem.20110283","article-title":"Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas","volume":"208","author":"Pilati","year":"2011","journal-title":"J Exp Med"},{"key":"10.1053\/j.semdp.2016.12.007_bib9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jhep.2011.07.018","article-title":"GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation","volume":"56","author":"Nault","year":"2012","journal-title":"J Hepatol"},{"key":"10.1053\/j.semdp.2016.12.007_bib10","doi-asserted-by":"crossref","first-page":"e27090","DOI":"10.4161\/onci.27090","article-title":"Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenoma","volume":"2","author":"Poussin","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1053\/j.semdp.2016.12.007_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/hep.28638","article-title":"Genotype-phenotype correlation of CTNNB1 mutations reveals different \u00df-catenin activity associated with liver tumor progression","author":"Rebouissou","year":"2016","journal-title":"Hepatology"},{"key":"10.1053\/j.semdp.2016.12.007_bib12","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1016\/S0168-8278(16)01666-4","article-title":"Nosology and molecular classification of hepatocellular adenomas","volume":"64","author":"Nault","year":"2016","journal-title":"J Hepatol"},{"key":"10.1053\/j.semdp.2016.12.007_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1055\/s-0031-1272837","article-title":"Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers","volume":"31","author":"Bioulac-Sage","year":"2011","journal-title":"Semin Liver Dis"},{"key":"10.1053\/j.semdp.2016.12.007_bib14","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.5858\/arpa.2013-0183-RA","article-title":"Update on the new classification of hepatic adenomas: clinical, molecular, and pathologic characteristics","volume":"138","author":"Dhingra","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.semdp.2016.12.007_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13000-016-0475-5","article-title":"Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis","volume":"11","author":"Margolskee","year":"2016","journal-title":"Diagn Pathol"},{"key":"10.1053\/j.semdp.2016.12.007_bib16","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/his.12539","article-title":"Gene mutations in hepatocellular adenomas","volume":"66","author":"Raft","year":"2015","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2016.12.007_bib17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/his.12011","article-title":"The value of immunophenotyping hepatocellular adenomas: consecutive resections at one UK centre","volume":"62","author":"Bellamy","year":"2013","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2016.12.007_bib18","doi-asserted-by":"crossref","first-page":"20994","DOI":"10.3390\/ijms160920994","article-title":"Current proceedings in the molecular dissection of hepatocellular adenomas: review and hands-on guide for diagnosis","volume":"16","author":"Goltz","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1053\/j.semdp.2016.12.007_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3350\/cmh.2016.0101","article-title":"Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma","volume":"22","author":"Roncalli","year":"2016","journal-title":"Clin Mol Hepatol"},{"key":"10.1053\/j.semdp.2016.12.007_bib20","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/hep.21743","article-title":"Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry","volume":"46","author":"Bioulac-Sage","year":"2007","journal-title":"Hepatology"},{"issue":"S2","key":"10.1053\/j.semdp.2016.12.007_bib21","first-page":"415A","article-title":"Different types of glutamine synthetase immunostaining in hepatocellular adenoma","volume":"24","author":"Bioulac-Sage","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2016.12.007_bib22","article-title":"Malignant transformation of a b-catenin inflammatory adenoma due to a S45 \u00df-catenin activating mutation present 12 years before","author":"Sempoux","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2016.12.007_bib23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/gut.2010.222109","article-title":"Changing trends in malignant transformation of hepatocellular adenoma","volume":"60","author":"Farges","year":"2011","journal-title":"Gut"},{"key":"10.1053\/j.semdp.2016.12.007_bib24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2217\/hep.14.14","article-title":"Malignant transformation of hepatocellular adenoma","volume":"1","author":"Sempoux","year":"2014","journal-title":"Hepatic Oncol"},{"key":"10.1053\/j.semdp.2016.12.007_bib25","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/modpathol.2015.83","article-title":"Pigmented hepatocellular adenomas have a high risk of atypia and malignancy","volume":"9","author":"Mounajjed","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2016.12.007_bib26","first-page":"598","article-title":"Pigmented hepatocellular adenoma with \u03b2-catenin activation: case report and literature review","volume":"15","author":"Coelho","year":"2016","journal-title":"Ann Hepatol"},{"key":"10.1053\/j.semdp.2016.12.007_bib27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/modpathol.2015.162","article-title":"Combined use of heat-shock protein 70 and glutamine synthetase is useful in the distinction of typical hepatocellular adenoma from atypical hepatocellular neoplasms and well-differentiated hepatocellular carcinoma","volume":"29","author":"Nguyen","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2016.12.007_bib28","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/PAI.0b013e31825d527f","article-title":"Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma","volume":"21","author":"Lagana","year":"2013","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1053\/j.semdp.2016.12.007_bib29","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hep.21068","article-title":"Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC","volume":"43","author":"Zucman-Rossi","year":"2006","journal-title":"Hepatology"},{"key":"10.1053\/j.semdp.2016.12.007_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/modpathol.2016.122","article-title":"Correlation of exon 3 \u03b2-catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinoma","author":"Hale","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2016.12.007_bib31","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1038\/ncomms3218","article-title":"High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions","volume":"4","author":"Nault","year":"2013","journal-title":"Nat Commun"},{"key":"10.1053\/j.semdp.2016.12.007_bib32","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1097\/PAS.0b013e3182653ece","article-title":"Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes","volume":"36","author":"Bioulac-Sage","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2016.12.007_bib33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1478-3231.2008.01849.x","article-title":"Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology","volume":"29","author":"Bioulac-Sage","year":"2009","journal-title":"Liver Int"},{"key":"10.1053\/j.semdp.2016.12.007_bib34","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.jhep.2015.06.017","article-title":"Hepatocellular nodules expressing markers of hepatocellular adenomas in Budd-Chiari syndrome and other rare hepatic vascular disorders","volume":"63","author":"Sempoux","year":"2015","journal-title":"J Hepatol"},{"key":"10.1053\/j.semdp.2016.12.007_bib35","doi-asserted-by":"crossref","DOI":"10.2350\/16-01-1761-CR.1","article-title":"Congenital extrahepatic portosystemic shunt (abernethy malformation type Ib) with associated hepatocellular carcinoma: case report and literature review","author":"Benedict","year":"2016","journal-title":"Pedia Dev Pathol"},{"key":"10.1053\/j.semdp.2016.12.007_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/modpathol.2015.119","article-title":"Inflammatory hepatocellular adenomas developed in the setting of chronic liver disease and cirrhosis","volume":"29","author":"Calderaro","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2016.12.007_bib37","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1159\/000438474","article-title":"Serum amyloid A-positive hepatocellular neoplasm: a new type of tumor arising in patients with advanced alcoholic disease","volume":"33","author":"Sasaki","year":"2015","journal-title":"Dig Dis"},{"key":"10.1053\/j.semdp.2016.12.007_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/modpathol.2014.121","article-title":"Immunohistochemical pitfalls in the diagnosis of hepatocellular adenomas and focal nodular hyperplasia: accurate understanding of diverse staining patterns is essential for diagnosis and risk assessment","volume":"28","author":"Kakar","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2016.12.007_bib39","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/modpathol.2013.114","article-title":"Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma","volume":"27","author":"Joseph","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2016.12.007_bib40","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.humpath.2012.07.019","article-title":"Atypical hepatocellular adenoma-like neoplasms with \u03b2-catenin activation show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas","volume":"44","author":"Evason","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2016.12.007_bib41","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/PAS.0000000000000624","article-title":"Immunostains used to subtype hepatic adenomas do not distinguish hepatic adenomas from hepatocellular carcinomas","volume":"40","author":"Liu","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2016.12.007_bib42","first-page":"1696","article-title":"Hepatocyte nuclear factor 1\u03b1-inactivated hepatocellular adenomatosis in a patient with maturity-onset diabetes of the young type 3: case report and literature review","volume":"112","author":"Hirata","year":"2015","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"key":"10.1053\/j.semdp.2016.12.007_bib43","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/PAS.0000000000000576","article-title":"Hepatocellular neoplasms arising in association with androgen use","volume":"40","author":"Gupta","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2016.12.007_bib44","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jhep.2012.09.030","article-title":"Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I","volume":"58","author":"Calderaro","year":"2013","journal-title":"J Hepatol"},{"key":"10.1053\/j.semdp.2016.12.007_bib45","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.clinre.2013.08.004","article-title":"Hepatocellular adenomatosis: what should the term stand for!","volume":"38","author":"Frulio","year":"2014","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1053\/j.semdp.2016.12.007_bib46","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/his.12326","article-title":"Coexistence of inflammatory hepatocellular adenomas with HNF1\u03b1-inactivated adenomas: is there an association?","volume":"64","author":"Castain","year":"2014","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2016.12.007_bib47","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1478-3231.2012.02786.x","article-title":"Hepatocellular adenoma subtypes: the impact of overweight and obesity","volume":"32","author":"Bioulac-Sage","year":"2012","journal-title":"Liver Int"},{"key":"10.1053\/j.semdp.2016.12.007_bib48","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/hep.21684","article-title":"Telangiectatic adenoma: an entity associated with increased body mass index and inflammation","volume":"46","author":"Paradis","year":"2007","journal-title":"Hepatology"},{"key":"10.1053\/j.semdp.2016.12.007_bib49","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-0035-1562952","article-title":"The Evolving role of nonalcoholic fatty liver disease in hepatic neoplasia: inflammatory hepatocellular adenoma in a man with metabolic syndrome","volume":"35","author":"Lefkowitch","year":"2015","journal-title":"Semin Liver Dis"},{"key":"10.1053\/j.semdp.2016.12.007_bib50","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1055\/s-0035-1567827","article-title":"Hepatocellular carcinoma arising in an HNF-1\u03b1-mutated adenoma in a 23-year-old woman with maturity-onset diabetes of the young: a case Report","volume":"35","author":"Stueck","year":"2015","journal-title":"Semin Liver Dis"},{"key":"10.1053\/j.semdp.2016.12.007_bib51","first-page":"398308","article-title":"Histological and immunohistochemical revision of hepatocellular adenomas: a learning experience","author":"Fonseca","year":"2013","journal-title":"Int J Hepatol"},{"key":"10.1053\/j.semdp.2016.12.007_bib52","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/PAS.0000000000000382","article-title":"Primary hepatic tumors with myxoid change: morphologically unique hepatic adenomas and hepatocellular carcinomas","volume":"39","author":"Salaria","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2016.12.007_bib53","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/PAS.0000000000000624","article-title":"Immunostains used to subtype hepatic adenomas do not distinguish hepatic adenomas from hepatocellular carcinomas","volume":"40","author":"Liu","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2016.12.007_bib54","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.gastro.2016.02.080","article-title":"Unexpected steatotic liver lesions","volume":"151","author":"De Vito","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1053\/j.semdp.2016.12.007_bib55","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1476-5926-2-6","article-title":"Association of adenoma and focal nodular hyperplasia: experience of a single French academic center","volume":"2","author":"Laurent","year":"2003","journal-title":"Comp Hepatol"},{"key":"10.1053\/j.semdp.2016.12.007_bib56","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.22417","article-title":"Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification","volume":"48","author":"Laumonier","year":"2008","journal-title":"Hepatology"},{"key":"10.1053\/j.semdp.2016.12.007_bib57","first-page":"11","article-title":"Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis","volume":"9","author":"Margolskee","year":"2016","journal-title":"Diagn Pathol"},{"issue":"Suppl 1","key":"10.1053\/j.semdp.2016.12.007_bib58","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000368144","article-title":"Pathological diagnosis of benign hepatocellular nodular lesions based on the new World Health Organization classification","volume":"87","author":"Kondo","year":"2014","journal-title":"Oncology"},{"key":"10.1053\/j.semdp.2016.12.007_bib59","unstructured":"Zhang L, Xu J. Molecular Classification of Hepatocellular Adenoma and its Clinical Significance. Zhonghua Bing Li Xue Za Zhi, Chinese. PubMed PMID: 25209000; 2014:Jun;43(6):428\u201330."},{"key":"10.1053\/j.semdp.2016.12.007_bib60","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.humpath.2013.12.011","article-title":"Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up","volume":"45","author":"Shafizadeh","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2016.12.007_bib61","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4132\/KoreanJPathol.2013.47.5.411","article-title":"Clinicopathological analysis of hepatocellular adenoma according to new bordeaux classification: report of eight korean cases","volume":"47","author":"Kim","year":"2013","journal-title":"Korean J Pathol"},{"key":"10.1053\/j.semdp.2016.12.007_bib62","first-page":"243","article-title":"Retrospective study of hepatocellular adenomas based on the phenotypic classification system: a report from China","volume":"29","author":"Pan","year":"2014","journal-title":"Histol Histopathol"},{"key":"10.1053\/j.semdp.2016.12.007_bib63","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.clinre.2013.04.008","article-title":"Benign hepatocellular nodules: what have we learned using the patho-molecular classification","volume":"37","author":"Sempoux","year":"2013","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1053\/j.semdp.2016.12.007_bib64","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.path.2013.03.008","article-title":"Hepatocellular Adenomas: WHO classification and immunohistochemical workup","volume":"6","author":"Paradis","year":"2013","journal-title":"Surg Pathol Clin"},{"key":"10.1053\/j.semdp.2016.12.007_bib65","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jhep.2016.04.001","article-title":"Clinical practice guidelines on the management of benign liver tumours","volume":"65","author":"EASL","year":"2016","journal-title":"J Hepatol"},{"issue":"Sup S1","key":"10.1053\/j.semdp.2016.12.007_bib66","article-title":"Glutamine synthetase immunohistochemical staining patterns correlate with molecular abnormalities of b-catenin pathway in hepatocellular adenoma","volume":"64","author":"Calderaro","year":"2016","journal-title":"Hepatology"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257016301137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257016301137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T16:17:13Z","timestamp":1658247433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257016301137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0740257016301137"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2016.12.007","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatocellular adenoma: Classification, variants and clinical relevance","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2016.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}